{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:12:05Z","timestamp":1768349525070,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000601","name":"De Montfort University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000857","name":"Loughborough University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejmech.2020.112871","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T12:15:24Z","timestamp":1601900124000},"page":"112871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-5826","authenticated-orcid":false,"given":"William J.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3381-592X","authenticated-orcid":false,"given":"Annie E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Lauga-Cami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George W.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randolph R.J.","family":"Arroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheraz","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kuzikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Ellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuldip","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Schirmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Botana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatchakorn","family":"Eurtivong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avninder S.","family":"Bhambra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejmech.2020.112871_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pt.2018.08.006","article-title":"The long wait for a new drug for human African trypanosomiasis","volume":"34","author":"Baker","year":"2018","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112871_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","article-title":"Melarsoprol resistance in African trypanosomiasis","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol."},{"issue":"10116","key":"10.1016\/j.ejmech.2020.112871_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","article-title":"Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial","volume":"391","author":"Mesu","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112871_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkv376","article-title":"Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei","volume":"71","author":"Wyllie","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"38","key":"10.1016\/j.ejmech.2020.112871_bib5","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1073\/pnas.1807915115","article-title":"Clinical and veterinary trypanocidal benzoxaboroles target CPSF3","volume":"115","author":"Wall","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2020.112871_bib6","doi-asserted-by":"crossref","first-page":"112018","DOI":"10.1016\/j.ejmech.2019.112018","article-title":"C6-O-alkylated 7-deazainosine nucleoside analogues: discovery of potent and selective anti-sleeping sickness agents","volume":"188","author":"Hulpia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112871_bib7","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.ejmech.2020.112871_bib8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/molecules22081210","article-title":"Chalcone derivatives: promising starting points for drug design","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112871_bib9","doi-asserted-by":"crossref","first-page":"172722","DOI":"10.1016\/j.ejphar.2019.172722","article-title":"Sofalcone, a gastroprotective drug, covalently binds to KEAP1 to activate Nrf2 resulting in anti-colitic activity","volume":"865","author":"Kim","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112871_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.tpj.6500320","article-title":"Genetic factors influencing Pyrimidine-antagonist chemotherapy","volume":"5","author":"Maring","year":"2005","journal-title":"Pharmacogenomics J."},{"issue":"17","key":"10.1016\/j.ejmech.2020.112871_bib11","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/cmdc.201800404","article-title":"Brain-penetrant triazolopyrimidine and phenylpyrimidine microtubule stabilizers as potential leads to treat human African trypanosomiasis","volume":"13","author":"Monti","year":"2018","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112871_bib12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1021\/acs.jmedchem.7b01654","article-title":"Species-selective pyrimidineamine inhibitors of trypanosoma brucei S-adenosylmethionine decarboxylase","volume":"61","author":"Volkov","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112871_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmech.2017.01.027","article-title":"Synthesis and antitrypanosomal activities of novel pyridylchalcones","volume":"128","author":"Bhambra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112871_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2015.11.043","article-title":"Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes","volume":"108","author":"Bhambra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112871_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0040-4020(02)01560-0","article-title":"Solution-phase parallel synthesis of 4,6-diaryl-pyrimidine-2-ylamines and 2-amino-5,5-disubstituted-3,5-dihydro-imidazole-4-ones via a rearrangement","volume":"59","author":"Varga","year":"2003","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112871_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cmdc.201900544","article-title":"Structure\u2212Activity relationships of cinnamate ester analogues as potent antiprotozoal agents","volume":"15","author":"Bernal","year":"2019","journal-title":"ChemMedChem"},{"issue":"11\u201312","key":"10.1016\/j.ejmech.2020.112871_bib17","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s00044-018-2253-2","article-title":"Synthesis, antitrypanosomal activity and molecular docking studies of pyrimidine derivatives","volume":"27","author":"de Melo","year":"2018","journal-title":"Med. Chem. Res."},{"issue":"17","key":"10.1016\/j.ejmech.2020.112871_bib18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2174\/1389557515666160509125243","article-title":"The inhibition of cysteine proteases rhodesain and TbCatB: a valuable approach to treat human African trypanosomiasis","volume":"16","author":"Ettari","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112871_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pharmthera.2017.06.004","article-title":"Targeting cysteine proteases in trypanosomatid disease drug discovery","volume":"180","author":"Ferreira","year":"2017","journal-title":"Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112871_bib20","first-page":"1513","article-title":"Comparative molecular docking of antitrypanosomal natural products into multiple trypanosoma brucei","volume":"14","author":"Ogungbe","year":"2009","journal-title":"Drug Targets. Molecules"},{"issue":"9","key":"10.1016\/j.ejmech.2020.112871_bib21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.bmcl.2018.03.039","article-title":"Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent","volume":"28","author":"Zhang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"38","key":"10.1016\/j.ejmech.2020.112871_bib22","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112871_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1747-0285.2012.01416.x","article-title":"Novel cruzain inhibitors for the treatment of chagas\u2019 disease","volume":"80","author":"Rogers","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112871_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1008354229396","volume":"18","author":"Dalvit","year":"2000","journal-title":"J.\u00a0Biomol. NMR"},{"issue":"12","key":"10.1016\/j.ejmech.2020.112871_bib25","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","article-title":"Characterization of ligand binding by saturation transfer difference NMR spectroscopy","volume":"38","author":"Mayer","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112871_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10858-014-9848-9","article-title":"Comparison of the sensitivities of WaterLOGSY and saturation transfer difference NMR experiments","volume":"60","author":"Antanasijevic","year":"2014","journal-title":"J.\u00a0Biomol. NMR"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112871_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm701020f","article-title":"SALMON: solvent accessibility, ligand binding, and mapping of ligand orientation by NMR spectroscopy","volume":"51","author":"Ludwig","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112871_bib28","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1080\/14756366.2019.1636235","article-title":"1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery","volume":"34","author":"Raingeval","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112871_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/2472555218823171","article-title":"Accelerating drug discovery efforts for trypanosomatidic infections using an integrated transnational academic drug discovery platform","volume":"24","author":"Moraes","year":"2019","journal-title":"SLAS discovery: advancing life sciences R & D"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112871_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2020.112871_bib31","unstructured":"wwwccdccamacuk. (n.d.). GOLD - Protein Ligand Docking Software - the Cambridge Crystallographic Data Centre (CCDC).."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112871_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112871_bib33","doi-asserted-by":"crossref","unstructured":"Fujitsu Scigress, version 2.8.1; 2018","DOI":"10.1016\/S0969-4765(18)30149-8"},{"issue":"25","key":"10.1016\/j.ejmech.2020.112871_bib34","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112871_bib35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00894-007-0233-4","article-title":"Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements","volume":"13","author":"Stewart","year":"2007","journal-title":"J.\u00a0Mol. Model."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112871_bib36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/cmdc.201300112","article-title":"Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human Cathepsin L","volume":"8","author":"Ehmke","year":"2013","journal-title":"ChemMedChem"},{"issue":"12","key":"10.1016\/j.ejmech.2020.112871_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acsmedchemlett.6b00276","article-title":"Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain","volume":"7","author":"Latorre","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"27","key":"10.1016\/j.ejmech.2020.112871_bib38","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1021\/jacs.6b03052","article-title":"Quantum chemical-based protocol for the rational design of covalent inhibitors","volume":"138","author":"Schirmeister","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112871_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystal. Sec. C Struct. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:19:51Z","timestamp":1759328391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420308436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":39,"alternative-id":["S0223523420308436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112871","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112871"}}